tiprankstipranks
Prescient Therapeutics Limited (PSTTF)
OTHER OTC:PSTTF

Prescient Therapeutics Limited (PSTTF) Stock Price & Analysis

5 Followers

PSTTF Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Financials

Annual

PSTTF FAQ

What was Prescient Therapeutics Limited’s price range in the past 12 months?
Currently, no data Available
What is Prescient Therapeutics Limited’s market cap?
Currently, no data Available
When is Prescient Therapeutics Limited’s upcoming earnings report date?
Prescient Therapeutics Limited’s upcoming earnings report date is Feb 23, 2024 which is 35 days ago.
    How were Prescient Therapeutics Limited’s earnings last quarter?
    Prescient Therapeutics Limited released its earnings results on Aug 24, 2023. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
      Is Prescient Therapeutics Limited overvalued?
      According to Wall Street analysts Prescient Therapeutics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Prescient Therapeutics Limited pay dividends?
        Prescient Therapeutics Limited does not currently pay dividends.
        What is Prescient Therapeutics Limited’s EPS estimate?
        Prescient Therapeutics Limited’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Prescient Therapeutics Limited have?
        Currently, no data Available
        What happened to Prescient Therapeutics Limited’s price movement after its last earnings report?
        Prescient Therapeutics Limited reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
          Which hedge fund is a major shareholder of Prescient Therapeutics Limited?
          Currently, no hedge funds are holding shares in PSTTF
          ---

          Prescient Therapeutics Limited Stock Smart Score

          4
          Neutral
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Fundamentals

          Return on Equity
          -32.65%
          Trailing 12-Months
          Asset Growth
          54.44%
          Trailing 12-Months

          Company Description

          Prescient Therapeutics Limited

          Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Durect
          Advaxis
          Verastem
          Akari Therapeutics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis